Skip to content
Parakho

Strides Pharma Science Ltd

NSE STARBSE 532531strides.com

Q1 FY27, unaudited

Revenue
₹582.65 Cr
Profit after tax
₹72.93 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations582.65+16.85%2,180.14
Other income1.48−16.10%123.06
Total income584.12+16.74%2,303.20
Employee benefit expense102.40+8.89%381.60
Finance costs28.51−6.37%113.77
Depreciation & amortisation25.73+16.22%91.24
Total expenses575.77+18.97%2,100.10
Profit before tax84.76+416.72%203.10
Tax expense11.83+287.11%19.47
Profit after tax72.93+446.40%183.64
Total comprehensive income96.18+1,224.85%126.95
Earnings per share
Earnings per share, basic₹7.91₹19.92
Earnings per share, diluted₹7.91₹19.92

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Strides Pharma Science reported FY26 revenue of INR48,587 million, up 6.4% year-on-year, with EBITDA of INR925 crores growing 15% and EBITDA margin expanding to 19%. Management attributed the revenue shortfall against expectations to a weaker US flu season and donor funding challenges in access markets, while highlighting 21% growth in Ex-US markets and a shift in revenue mix toward Ex-US business. The company also announced the appointment of Ramaraju, current COO, as Executive Director, and the Board recommended a dividend of INR5 per share.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 48 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 19 Aug 2026.